Sector News

DuPont’s nutritional arm eyed by Royal DSM

September 17, 2019
Chemical Value Chain

DuPont’s nutrition and bioscience business may be up for sale and Amsterdam’s Royal DSM may want to buy it, according to a report from Bloomberg.

Download Now: To be a profitable investor you first need to know the rules. Get Jim Cramer’s 25 Rules for Investing Special Report

The business could be valued at $25 billion, people who asked not to be identified told Bloomberg.

The specialty chemicals maker has been considering the sale or spinoff of its nutrition business, and has been in the process of selecting advisers to sort out offers for the division for some time, according to confidential sources.

In August, Bloomberg said that DuPont wanted to rid itself of the arm, and may be looking into a Reverse Morris Trust, a tax-free merger, as well.

Shares of DuPont fell 1.41% to $72.50 on Monday.

By Cherella Cox Owoyelu

Source: The Street

Related News

April 2, 2020

Europe chemical prices crash, 32% of refinery capacity restricted, offline

Chemical Value Chain

With European building block chemical contracts now settling at record decreases, and 32% of European refineries now offline or at reduced operating rates, more evidence of the damage caused by […]

April 2, 2020

Nouryon to acquire Sasol’s metal alkyls business

Chemical Value Chain

Nouryon has entered into an agreement to acquire the merchant triethyl aluminum (TEAL) business of Sasol, including its specialty fleet of returnable cylinders. TEAL is a metal alkyl essential in […]

April 2, 2020

Arkema to divest MMA/PMMA business, part of fluorogases

Chemical Value Chain

At a strategy meeting today with analysts and the press, conducted by phone due to the coronavirus disease 2019 (COVID-19) pandemic, Arkema’s top executives, headed by CEO Thierry Le Hénaff, […]